(Circulation. 1999;99:1400-1403.)
© 1999 American Heart Association, Inc.
Editorials |
From the Department of Cardiology, Heart Lung Institute, Utrecht University Hospital, Utrecht, Netherlands.
Correspondence to Cornelius Borst, MD, PhD, Professor of Experimental Cardiology, Heart Lung Institute, Utrecht University Hospital (Room G02.523), PO Box 85500, 3508 GA Utrecht, Netherlands. E-mail c.borst{at}hli.azu.nl
Key Words: Editorials bypass surgery coronary
In their recent editorial "Minimally Invasive Coronary Bypass: A Dissenting Opinion," Bonchek and Ullyot1 express concerns about ill-guided attempts to deviate from the conventional revascularization procedure that is "safe, effective, durable, reproducible, complete, versatile, and teachable." In the present editorial, an experimental perspective on the search for less invasive surgical strategies is provided that will convey an opposite opinion. First, a brief reappraisal is warranted of the safety of coronary artery bypass graft surgery (CABG) during cardiac arrest supported by cardiopulmonary bypass (CPB).
Safety of Conventional CABG
The great majority of CABG patients benefit greatly from
coronary revascularization, but the
surgical procedure is not without adverse effects. The Society of
Thoracic Surgeons (STS) National Cardiac Surgery Database (January
1998) lists complications of 170 895 CABG-only operations, including
13 736 reoperations, performed in the United States in 1996. Operative
mortality was 2.9% (2.5% in men, 4.0% in women). Operative mortality
increases with age, from 1.1% at age 20 to 50 years to 7.2% at 81 to
90 years. In only 65.4% of procedures were no complications reported.
Most complications are listed in the
Table
.
|
Another way to assess the clinical outcome of conventional CABG is to
analyze hospital discharge data from health insurance
records.2 Of 101 812 patients
65 years old operated
on in January through October 1993 in the United States, 4.3% died in
hospital. Of particular concern are patients (3.6%) who were
discharged to a nonacute-care facility.3 Owing to
complications, 10.2% were discharged late (>14 days) to home. Thus,
81.9% were discharged to home in
14 days. In the first 2 months
after discharge to home, 0.7% died and 9.9% were readmitted for
cardiovascular, respiratory, or cerebrovascular
reasons.
Although each of these numbers needs to be carefully interpreted in its
context, the Table
and the health insurance data,2
taken together, would seem to fall short of the "excellent
outcomes" attributed to conventional CABG by Bonchek and
Ullyot.1
Mechanisms of Adverse Effects
The adverse effects of conventional CABG have been recognized from the beginning and are well documented.4 After 30 years of technical and surgical evolution, however, the approach to coronary surgery has remained basically unaltered.4 Worldwide, virtually all 800 000 patients per year are exposed to median sternotomy, full heparinization, CPB with aortic cross-clamping, global ischemic cardiac arrest with or without cooling, saphenous vein harvest and aortic side-clamping, and an anesthetic regimen specific to CPB-supported CABG.
There are solid reasons to perform coronary surgery on an arrested heart. The surgeon is provided with a still field, absence of blood in the anastomotic area, and an empty, flaccid heart that can be manipulated easily to expose all coronary branches. As enumerated above, however, these technical advantages to the surgeon do not come with a free ride to the patient, in particular the elderly patient.2 3 4
The adverse cerebral effects, including neurocognitive impairment, are attributed to a combination of particulate emboli generated by manipulation of the ascending aorta, microthrombi due to platelet activation, and gaseous emboli, as well as cerebral sequelae of the extracorporeal circulationinduced whole-body inflammatory response. The latter is manifested by fever, activation of leukocytes, complement, C-reactive protein and a host of other factors, arrhythmias, endothelial dysfunction, interstitial fluid accumulation, pulmonary dysfunction, renal dysfunction, and organ failure in severe cases. Emboli may contribute to organ dysfunction. Prolonged ischemic cardiac arrest and extracorporeal circulation may cause hemodynamic disorders and bleeding disorders necessitating administration of blood products.
The mortality and morbidity of conventional CABG invite exploration of surgical revascularization strategies with fewer adverse effects. In addition, the current expansion of coronary angioplasty by stenting is a potent stimulus to search for coronary surgery procedures with substantially reduced mortality, morbidity, and reconvalescence period.
Minimally Invasive CABG: A Minimal-Adverse-Effects Approach
The terminology for less invasive CABG is utterly confusing. "Minimally invasive" refers to procedures that range from thoracoscopic CABG with CPB (peripheral cannulation) to median sternotomy CABG on the beating heart. In between, MIDCAB refers to direct-vision left internal thoracic artery (LITA) grafting to the left anterior descending coronary artery (LAD) on the beating heart through a 5- to 10-cm left anterolateral thoracotomy (also referred to as LAST operation).5 OPCAB refers to off-pump CABG, whatever the access. ECAB refers to endoscopic CABG, whether off-pump or on-pump.
The Babylonian confusion in terminology originates from the 2 diverging starting points in the search for less invasive methods. The approach developed at Stanford was inspired by the advent of video-assisted thoracic surgery, but it retained CPB with peripheral cannulation.6 The beating-heart approach,7 8 9 in contrast, was inspired by the recognition that the major adverse events are due to CPB rather than to median sternotomy.10 11 A third approach combined beating-heart surgery and limited access,5 8 12 sometimes including thoracoscopic LITA takedown.13
In our view, a "minimally invasive" approach to coronary surgery is to be regarded as a "minimal adverse effects" approach that starts by omitting CPB and cardiac arrest. In the assessment of minimally invasive CABG results, the distinction between off-pump and on-pump procedures is crucial.
Without CPB
Omitting CPB and cardiac arrest gives rise to alternative problems. First, beating-heart coronary motion hampers anastomosis suturing. Second, interruption of recipient artery flow may induce regional ischemia, arrhythmias, and hemodynamic deterioration. Third, perforating branches in the vicinity of the arteriotomy may produce torrential retrograde blood flow in the arteriotomy that obscures its edges and hampers suturing. Fourth, anterior displacement of the beating heart to expose posterior branches interferes with normal pump function and causes a drop in cardiac output. Fifth, in contrast to the arrested, decompressed heart, the (enlarged) beating heart may leave limited space in the thorax for the surgeon to work in comfortably. Sixth, identification of the target vessel may be more difficult. Seventh, to date, an intramyocardial course of the coronary artery and diffuse disease are relative contraindications. Thus, by avoiding a host of adverse effects of CPB and cardiac arrest, a host of new problems is generated. Most of these issues, however, are being dealt with.
Anesthetic and Postoperative Regimen
Without CPB, a modified anesthetic
perioperative and postoperative regimen is required to
deal with the different surgery and to allow extubation in the
operating room, to limit or obviate intensive care stay, and to allow
early discharge.
Coronary Motion
Microsurgery seems to be incompatible with a moving target. In
some centers, however, the distal anastomosis has been accomplished in
>1000 patients by means of traction sutures and instruments held by
the assistant.9 10 11 The introduction of mechanical
stabilizers in 19955 8 14 15 16 greatly facilitated local
epicardial motion restraint to
1x1 mm in the epicardial plane
when the target site is immobilized by means of a tissue
stabilizer attached to the operating
table14 or to the rib
retractor.15 Mechanical stabilizers cause negligible
injury14 15 and hardly affect stroke
volume15 16 unless the heart is displaced.16
An alternative, still experimental approach is the brief, drug-induced
ventricular asystole that allows placing 1
stitch.17 Once that is done, ventricular
pacing is resumed.
Angiographic Patency
There is little consensus on the precise "gold standard" for
angiographic patency.18 One recent gold standard is based
on 645 patients from an international multicenter randomized
trial.19 At a mean follow-up of 11 days, a widely patent
LITA-to-LAD graft (stenosis <50%) was found in 584 patients
(91.0%). After CABG without CPB using a mechanical stabilizer, similar
patency rates of
90% are reported in single- and multiple-vessel
cases, both at early5 12 18 20 21 and at 6-month
follow-up.8 22 A mechanical stabilizer significantly
improves early angiographic results and event-free survival in the
first 1.5 years.20
Interruption of Coronary Flow
Owing to the presence of well-developed collateral circulation in
patients with coronary artery disease, 10- to 20-minute
interruption of coronary flow is remarkably well tolerated
under the conditions of the operation. In rare cases, mostly when the
right coronary artery is occluded, hemodynamic
instability may arise from arrhythmia or ischemia. A
temporary luminal shunt,23 arteriotomy
seal,24 or distal perfusion cannula may prevent this
complication.
Blood
The temporary luminal shunt23 or 200-µm-thick
arteriotomy seal24 may also be used to advantage in
preventing blood from obscuring the arteriotomy edges. Another way to
fight blood in the arteriotomy is by saline spray combined with a
blower.
Hemodynamic Deterioration
Off-pump CABG has remained mainly limited to the LAD and a
diagonal branch, the right coronary artery, and the posterior
descending artery. Together with the lack of space and unfavorable
angle of attack, grafting of circumflex branches is still a major
challenge owing to hemodynamic deterioration when the
beating heart is retracted anteriorly to expose posterior branches in a
median sternotomy approach. In the porcine model,16 the
40% drop in stroke volume is attributed to deformation of primarily
the right ventricle. At the expense of augmented preloads, the
Trendelenburg maneuver is capable of restoring arterial
pressure. In selected patients with multivessel disease, beating-heart
revascularization of posterior branches through
median sternotomy is feasible but demanding.8 Inotropic
support is sometimes needed.8
Beating-Heart Coronary Surgery
According to industry estimates, >30 000 CABG operations
worldwide have been performed on the beating heart by use of a
commercially available mechanical stabilizer, through both full and
limited access. Current indications include favorable coronary
anatomy and high-risk cases. Coronary surgery on the
beating heart is more demanding than conventional surgery. The first
part of the learning curve, however, can be shortened by training in an
animal laboratory. In centers that have initiated a program for CABG on
the beating heart using a mechanical stabilizer, soon 10% to 15% of
cases are being performed without CPB. This percentage will rise
substantially when grafting of circumflex branches becomes more
generally feasible.
Arterial Conduits
Without cross-clamping and puncturing of the ascending aorta, only the side-biting clamp for the proximal anastomosis of the saphenous vein graft remains as a source of plaque embolization. Arterial grafts, if used exclusively,25 will abolish this last cause of cerebral embolization from manipulation of the aorta. Avoiding the long wound from vein harvesting in the leg will further contribute to reduction in postoperative pain and morbidity. If no adequate arterial conduits are available, less invasive, endoscopic methods to harvest the saphenous vein are now available that are associated with less pain and fewer wound complications.26 In addition, novel devices are being developed to construct the proximal anastomosis on the aorta without a side-biting clamp.
Access Reduction
A limited-access approach5 8 12 13 15 18 20 21 is attractive in cases that require limited revascularization, eg, a small anterolateral thoracotomy for LITA grafting to the LAD territory or subxyphoidal laparotomy for gastroepiploic artery grafting to the distal right coronary artery or proximal posterior descending artery. As long as revascularization on the beating heart of posterior branches remains too great a challenge, a hybrid approach to multivessel disease may be considered in which only the LAD territory is revascularized by LITA grafting through minithoracotomy, and other lesions are treated by percutaneous angioplasty.27
Randomized Trials
The first randomized study (62 patients) on isolated LITA-to-LAD grafting on the beating heart28 reports significant reductions in systemic inflammatory response, postoperative morbidity, and hospital stay compared with conventional coronary surgery. Based on promising results in the first 100 patients in Utrecht,8 the Netherlands National Health Insurance Council has funded a multicenter study that started in March 1998. This study involves 2 randomized trials in which it is intended to revascularize by arterial grafts only. One trial compares multivessel CABG without CPB using a mechanical tissue stabilizer versus conventional CABG with CPB. The second trial compares multivessel CABG without CPB using a stabilizer versus stenting. Both trials include angiographic follow-up at 1 year in a randomized subset of the 560 patients.
Closed-Chest Thoracoscopic CABG
The thoracoscopic coronary surgery approach developed originally at Stanford6 uses peripheral cannulation for CPB and global cardiac arrest. On top of augmented complexity, surgery time, and costs, this adds the risks of aortic dissection and other peripheral complications21 to the adverse effects of CPB and prolonged myocardial ischemia. Currently, the "port-access" approach is performed under direct vision through a 5- to 8-cm thoracotomy port.21
Since May of 1998, in at least 3 European centers, thoracoscopic attempts at coronary surgery on the arrested heart have been resumed with the aid of recently developed 3D visualization and master-slave robotic surgery systems. The latter systems will soon open the way to thoracoscopic bypass grafting on the beating heart using a stabilizer suited to closed-chest application.14 Ultimately, however, a facilitated coronary anastomosis technique, as for example a stapling device,29 once modified for thoracoscopic application, may allow closed-chest beating-heart coronary surgery by relatively simple and inexpensive means.
Conclusions
Early reports begin to provide support for the postulated benefits of coronary surgery on the beating heart (whether through full or limited access): less mortality and morbidity, earlier return to normal activities, lower costs, and equivalent angiographic quality of the bypasses and event-free survival in the first year. In most hands, optimal coronary immobilization by a mechanical stabilizer remains a prerequisite to construct a technically satisfactory distal anastomosis.20
The major obstacle to beating-heart coronary surgery is hemodynamic deterioration when, in a median sternotomy approach, the posterior side of the beating heart is exposed. There are no fundamental reasons, however, to assume that this obstacle cannot be largely surmounted in the near future. In addition, the issue of "completeness" in revascularization deserves reconsideration. In some instances, the cardiac surgeon and the interventional cardiologist may join therapeutic hands.
Reduction in access in combination with maintaining direct vision is likely to contribute in selected cases to a further reduction in adverse effects. Closed-chest coronary stabilization methods, 3D visualization, and thoracoscopic master-slave robotic surgery systems will allow closed-chest CABG without CPB in the near future. Facilitated anastomosis techniques may accelerate this development at lower costs.
It is conceivable that 5 years hence >50% of coronary surgery will be performed on the beating heart, mainly with arterial conduits, in part through limited access and, depending on costs, in part through the closed-chest approach. These formidable changes in surgical strategy and methods require careful exploration in small incremental steps. One ought not to be deterred from searching for solutions to great technical and surgical challenges,1 if so much is ultimately to be gained for so many patients.
Footnotes
The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.
References
This article has been cited by other articles:
![]() |
C. Prasser, M. Abbady, C. Keyl, A. Liebold, M. Tenderich, A. Philipp, and C. Wiesenack Effect of a miniaturized extracorporeal circulation (MECCTMSystem) on liver function Perfusion, July 1, 2007; 22(4): 245 - 250. [Abstract] [PDF] |
||||
![]() |
I. J. Ferreira-Gonzalez, A. Ribera, P. Cascant, G. Permanyer-Miralda, and for the ARCA study group Outcomes in off-pump vs. on-pump coronary artery bypass grafting stratified by pre-operative risk profile: an assessment using propensity score Eur. Heart J., October 2, 2006; 27(20): 2473 - 2480. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Glance, A. W. Dick, T. M. Osler, and D. B. Mukamel The Relation Between Surgeon Volume and Outcome Following Off-Pump vs On-Pump Coronary Artery Bypass Graft Surgery Chest, August 1, 2005; 128(2): 829 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J Murphy, R. Ascione, and G. D Angelini Coronary artery bypass grafting on the beating heart: surgical revascularization for the next decade? Eur. Heart J., December 1, 2004; 25(23): 2077 - 2085. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Reuthebuch, A. Haussler, M. Genoni, R. Tavakoli, D. Odavic, A. Kadner, and M. Turina Novadaq SPY: Intraoperative Quality Assessment in Off-Pump Coronary Artery Bypass Grafting Chest, February 1, 2004; 125(2): 418 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. van Andel, P. V. Pistecky, and C. Borst Mechanical properties of porcine and human arteries: implications for coronary anastomotic connectors Ann. Thorac. Surg., July 1, 2003; 76(1): 58 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Karamanoukian, R. F. Brodman, and P. S. Aoukar Will the Cardiovascular Interventionist of the Future Be a Cardiac Surgeon, Interventional Cardiologist, or Interventional Radiologist? Angiology, July 1, 2003; 54(4): 385 - 389. [PDF] |
||||
![]() |
F. Unger, P. W. Serruys, M. H. Yacoub, C. Ilsley, P. K. Paulsen, T. T. Nielsen, L. Eysmann, and F. Kiemeneij Revascularization in multivessel disease: Comparison between two-year outcomes of coronary bypass surgery and stenting J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 809 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Nathoe, D. van Dijk, E. W.L. Jansen, W. J.L. Suyker, J. C. Diephuis, W.-J. van Boven, A. B. de la Riviere, C. Borst, C. J. Kalkman, D. E. Grobbee, et al. A Comparison of On-Pump and Off-Pump Coronary Bypass Surgery in Low-Risk Patients N. Engl. J. Med., January 30, 2003; 348(5): 394 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Amodeo, H. W. Donias, G. D'Ancona, E. L. Hoover, and H. L. Karamanoukian The Hybrid Approach to Coronary Artery Revascularization: Minimally Invasive Direct Coronary Artery Bypass with Percutaneous Coronary Intervention Angiology, November 1, 2002; 53(6): 665 - 669. [Abstract] [PDF] |
||||
![]() |
Z. Straka, P. Brucek, T. Vanek, J. Votava, and P. Widimsky Routine immediate extubation for off-pump coronary artery bypass grafting without thoracic epidural analgesia Ann. Thorac. Surg., November 1, 2002; 74(5): 1544 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Bonchek, D. van Dijk, P. P.T. de Jaegere, E. W.L. Jansen, H. M. Nathoe, J. C. Diephuis, C. Borst, E. Buskens, D. E. Grobbee, A. P. Nierich, et al. Off-Pump Versus On-Pump Coronary Bypass Surgery * Response Circulation, June 25, 2002; 105 (25): e198 - e198. [Full Text] [PDF] |
||||
![]() |
N.A. Scott, J.L. Knight, B.P. Bidstrup, H. Wolfenden, R.N. Linacre, and G.J. Maddern Systematic review of beating heart surgery with the Octopus(R) Tissue Stabilizer Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 804 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Buijsrogge, C. W.J. Verlaan, M. H.P. van Rijen, P. F. Grundeman, and C. Borst Coronary end-to-side sleeve anastomosis using adhesive in off-pump bypass grafting in the pig Ann. Thorac. Surg., May 1, 2002; 73(5): 1451 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Buijsrogge, P. F. Grundeman, C. W. J. Verlaan, and C. Borst Unconventional vessel wall apposition in off-pump porcine coronary artery bypass grafting: Low versus high graft flow J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 341 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vanek, Z. Straka, P. Brucek, and P. Widimsky Thoracic epidural anesthesia for off-pump coronary artery bypass without intubation Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 858 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Trehan, M. Mishra, O. P. Sharma, A. Mishra, and R. R. Kasliwal Further reduction in stroke after off-pump coronary artery bypass grafting: a 10-year experience Ann. Thorac. Surg., September 1, 2001; 72(3): S1026 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abizaid, M. A. Costa, M. Centemero, A. S. Abizaid, V. M.G. Legrand, R. V. Limet, G. Schuler, F. W. Mohr, W. Lindeboom, A. G.M.R. Sousa, et al. Clinical and Economic Impact of Diabetes Mellitus on Percutaneous and Surgical Treatment of Multivessel Coronary Disease Patients: Insights From the Arterial Revascularization Therapy Study (ARTS) Trial Circulation, July 31, 2001; 104(5): 533 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Caputo, M. H. Chamberlain, F. Ozalp, M. J. Underwood, F. Ciulli, and G. D. Angelini Off-pump coronary operations can be safely taught to cardiothoracic trainees Ann. Thorac. Surg., April 1, 2001; 71(4): 1215 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bastiaanse, C. Borst, Y. J.M. van der Helm, K. H.H. Loo, and P. F. Grundeman Arteriotomy closure by glued patch in the porcine carotid artery Ann. Thorac. Surg., October 1, 2000; 70(4): 1384 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Imasaka, S. Morita, I. Nagano, M. Masuda, R. Tominaga, and H. Yasui Coronary artery bypass grafting on the beating heart evaluated with integrated backscatter Ann. Thorac. Surg., September 1, 2000; 70(3): 1049 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Scheltes, M. Heikens, P. V. Pistecky, C. J. van Andel, and C. Borst Assessment of patented coronary end-to-side anastomotic devices using micromechanical bonding Ann. Thorac. Surg., July 1, 2000; 70(1): 218 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Mack Is there a future for minimally invasive cardiac surgery? Eur. J. Cardiothorac. Surg., November 1, 1999; 16(suppl_2): S119 - S125. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Grundeman, C. Borst, C. W. J. Verlaan, H. Meijburg, C. M. Moues, and E. W. L. Jansen EXPOSURE OF CIRCUMFLEX BRANCHES IN THE TILTED, BEATING PORCINE HEART: ECHOCARDIOGRAPHIC EVIDENCE OF RIGHT VENTRICULAR DEFORMATION AND THE EFFECT OF RIGHT OR LEFT HEART BYPASS J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 316 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Damiano The minimally invasive direct coronary artery bypass procedure: What is its future role? J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 207 - 208. [Full Text] |
||||
![]() |
G. N. Olinger Informed advice Ann. Thorac. Surg., June 1, 1999; 67(6): 1545 - 1546. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |